ArticleLeukemia research2012

Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes.

Peter Noy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.